Microbot Medical Inc. (MBOT) vs Stereotaxis Inc. (STXS)

Microbot Medical Inc. and Stereotaxis Inc. are both Medical Instruments & Supplies companies. Stereotaxis Inc. is the larger, with a market value of $133.3M against $88.0M — 1.5× the size. Stereotaxis Inc. grew revenue faster over the last twelve months: −5.46% against −59.1%. Stereotaxis Inc. has the higher net margin (−78.5% vs −3,955.2%) and the higher return on invested capital (−203.6% vs −850.5%). Across the 17 metrics below, Stereotaxis Inc. leads on 12 and Microbot Medical Inc. on 5.

Valuation

Metric MBOT STXS Medical Instruments & Supplies median
P/E n/m n/m 34.17
P/S 208.11 4.32 2.83
P/B 1.25 10.62 2.82
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 16.08
EV/Sales 46.44 4.16 3.06
Earnings yield (18.75%) (18.46%) (1.84%)
Free cash flow yield (20.85%) (11.92%) 0.17%

Profitability

Metric MBOT STXS Medical Instruments & Supplies median
Gross margin (166.30%) 55.57% 54.62%
Operating margin (4,480.03%) (75.68%) 1.64%
Net margin (3,955.22%) (78.45%) 0.00%
Free cash flow margin (4,340.11%) (51.56%) 1.61%
Return on equity (32.91%) (344.36%) 0.00%
Return on assets (30.68%) (48.76%) 0.00%
Return on invested capital (850.51%) (203.58%) 0.00%

Growth

Metric MBOT STXS Medical Instruments & Supplies median
Revenue growth (TTM) (59.09%) (5.46%) 9.20%
EPS growth (last fiscal year) 60.27% 16.67% —
Revenue growth, 5-year CAGR 0.39% 3.99% 9.48%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MBOT STXS Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.08
Current ratio 18.56 1.42 2.49
Net debt to EBITDA 5.35 0.65 0.83

Dividend

Metric MBOT STXS Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 0.00 0.00

Size

Metric MBOT STXS Medical Instruments & Supplies median
Market cap 87.99m 133.27m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack